Same Indication

Furosemide vs Nivolumab

Furosemide vs Nivolumab: Overview

This comparison examines the pharmacological differences between Furosemide and Nivolumab.

Mechanism of Action

Furosemide: Loop diuretic inhibiting Na-K-2Cl cotransporter.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Furosemide — 2 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Furosemide — C12H11ClN2O5S.

Molecular Weight: Furosemide — 330.7440 g/mol.

Type: Furosemide — Small molecule; Nivolumab — Antibody.